The medical world has been waiting for a definitive answer to the question, “Why do people do bodybuilding?”
There is no definitive answer, and there has been plenty of conjecture.
There has been the idea that the reason bodybuilders compete is because they want to look like their idols, that they’re “bruising” and “in shape” for their parents, that it gives them the “best chance” to make money, that “it makes them feel good.”
There have been claims that bodybuilders are “trying to get rich,” that they are “in competition with themselves” and that “if you compete with yourself you’re going to fail.”
But it’s hard to find anything conclusive that has any real validity, because bodybuilding has never been proven to have any of the many medical problems that the sport currently has.
It’s also true that there have been studies that have found correlations between bodybuilders and other medical conditions, such as obesity, depression and cancer, but these studies have only been done in very small samples, in which the participants were young and not very healthy.
The most recent study to examine the effects of bodybuilding on health was conducted in a small study by Dr. Jeffrey A. Norenzayan, who found that bodybuilding “can significantly increase a person’s risk of developing certain cancers, including colon, prostate, breast, and thyroid cancers.”
In his study, the participants (who were between 21 and 34 years old) were divided into three groups, which were then followed for one year.
The first group was “matched” to the others.
This was the “control group,” which included no athletes.
The second group was matched to the controls and had a total of 28 healthy male volunteers who were free of any disease.
The third group was randomly assigned to one of the groups.
This included four athletes in each group, with no other contact with the controls.
They all did an initial exercise test on their own, and then they were asked to take part in a two-week training program.
The results of this study showed that the participants in the control group had significantly lower body mass indexes than the other two groups, and they had higher blood pressure, cholesterol and blood sugar levels.
These researchers also found that the control athletes had lower levels of inflammation, a risk factor for heart disease, and lower levels for type 2 diabetes.
In his paper, Norezayan noted that, “the effect of bodybuilders’ weight reduction and body mass index reductions is likely to be of concern because it may contribute to the formation of a negative body image and negatively impact self-esteem, which may lead to chronic disease in this group.”
However, Norenzayan’s study did not find that the athletes who participated in the exercise program were any more or less likely to develop certain medical conditions than those who did not participate.
In fact, the researchers found that, despite the weight reduction, there were still some health risks to bodybuilders who participated.
They found that: There was an increase in the risk of pancreatic cancer in the bodybuilders, but the increase was less than the change in risk of other cancers (such as breast cancer and colon cancer) (Pancreatic Cancer: The Next Generation, N.K. and E.E. O’Keefe, unpublished manuscript).
There was a significant decrease in the incidence of colorectal adenocarcinoma in the group that participated in exercise, but not in the controls, and a similar decrease in risk was observed in both the controls (Pct.
adenomas) and the athletes (PCT of colo.
The researchers also noted that they “did not find any differences in the prevalence of cancers of the breast or colon that are more common in the general population.”
They found no significant differences in lung cancer risk, heart disease risk, or diabetes risk.
Norenjayan concluded that, since these were small studies, “there is insufficient evidence to support the hypothesis that weight reduction alone causes cancer or other disease.”
But he added, “Our study shows that there are some benefits to weight reduction from the standpoint of preventing certain diseases, but that it does not necessarily reduce the risks of all the diseases we currently study.”
What about other bodybuilding competitions?
The results from the Noreziayan study are not encouraging.
Researchers at the University of California, Los Angeles (UCLA), found that while bodybuilders had a lower risk of having diabetes, they were at a greater risk of lung cancer and higher risk of heart disease and colon and rectal cancer than other people.
They also found the same thing in the study conducted by Norenzonan.
These findings, however, do not prove that the competition of bodybuilder-related bodybuilding is a bad thing.
But the studies that support the notion that competition can lead to health problems are small.
In the larger bodybuilding studies, participants are randomly assigned into two groups